GenderAffirming Hormone Therapy and the Risk of Tumors

Gender-Affirming Hormone Therapy and the Risk of Tumors

07:00 EST 24 Dec 2018 | Medscape

Are transgender individuals receiving gender-affirming hormone therapy at a greater risk for developing hormone-dependent tumors?
Clinical Endocrinology

Original Article: Gender-Affirming Hormone Therapy and the Risk of Tumors

More From BioPortfolio on "Gender-Affirming Hormone Therapy and the Risk of Tumors"